10.11.2014 - 11.11.2014
The balance of benefits and risks of a product is the basis for all key decisions in the pharma industry. Thus the balance must not be left to chance – it can be and should be effectively managed. This intensive course explores current opportunities made possible by the new legislation, advances in information technology and a new scientific methodology to enhance and modernise the approaches in the product lifecycle management.
Contact: DIA Europe
Phone: +41 61 225 51 51, Fax: +41 61 225 51 52